Zembrace Symtouch Solution
Product Images NDC 70792-809

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Zembrace Symtouch (NDC 70792-809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tonix Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zembrace 01)

Chemical structure of Sumatriptan Succinate, the active ingredient in Zembrace SymTouch 3 mg/0.5 mL solution for subcutaneous injection by Tonix Medicines, Inc.*

FDA Label Image

Image (Zembrace 02)

The image shows the packaging label for Zembrace SymTouch 3 mg/0.5 mL solution for subcutaneous injection. The label includes the brand and generic name Sumatriptan Succinate, and indicates it is a prescription drug by Tonix Medicines, Inc. The package likely contains prefilled syringes for administration.*

FDA Label Image

Image (Zembrace 03)

Illustration of the Zembrace SymTouch subcutaneous injection device showing labeled parts including the red cap, yellow needle guard, medicine viewing window, and red plunger rod. The device is white with labeled brand name on the body.*

FDA Label Image

Image (Zembrace 04)

An instructional illustration showing a hand holding a Zembrace SymTouch injection pen near the eye, with an arrow indicating where to check the expiration date printed on the pen. The expiration date format is marked as Exp: Mo./Yr.*

FDA Label Image

Image (Zembrace 05)

An instructional illustration showing a close-up view of the Zembrace SymTouch injection device with a focus on the viewing window containing the medication indicator. A hand is holding the device, and an eye symbol indicates the need to visually verify the indicator in the window before use.*

FDA Label Image

Image (Zembrace 06)

Illustration showing the Zembrace SymTouch autoinjector device for sumatriptan succinate 3 mg/0.5 mL subcutaneous solution, along with accompanying supplies including an alcohol swab, sterile cotton ball or gauze, and a biohazard-labeled puncture-resistant sharps container for safe disposal.*

FDA Label Image

Image (Zembrace 07)

An anatomical illustration showing recommended injection sites for a subcutaneous solution on the human body. The labeled sites include the upper outer arms, the abdomen, and the upper outer thighs.*

FDA Label Image

Image (Zembrace 08)

An instructional illustration showing a hand using a folded gauze or wipe to clean or prepare a site on a forearm, indicated by curved arrows. This image is likely part of directions for preparing a subcutaneous injection site for Zembrace SymTouch sumatriptan succinate solution.*

FDA Label Image

Image (Zembrace 09)

An instructional illustration showing a person holding a Zembrace SymTouch autoinjector with the cap removed. An arrow indicates the removal of the injector cap, depicted being held by another hand. A close-up inset shows the needle exposed in the device tip, demonstrating preparation for subcutaneous injection of the 3 mg/0.5 mL sumatriptan succinate solution.*

FDA Label Image

Image (Zembrace 10)

Illustration showing a hand holding and pressing a Zembrace SymTouch autoinjector device against the skin. The device is positioned for subcutaneous administration of the solution. The image demonstrates the proper injection technique by holding the device firmly in place.*

FDA Label Image

Image (Zembrace 11)

An instructional diagram showing two steps for using a subcutaneous autoinjector. The first step shows a hand pressing the device until it clicks once, followed by holding the device down. The second step shows the same hand holding down until a second click is heard, with instructions to continue holding down slowly for a count of five seconds.*

FDA Label Image

Image (Zembrace 12)

An instructional illustration showing a hand holding the Zembrace SymTouch subcutaneous injection device vertically above a skin surface. The label notes that the yellow needle guard is locked over the needle, indicating the device is ready for use.*

FDA Label Image

Image (Zembrace 13)

An instructional illustration showing a hand holding the Zembrace SymTouch autoinjector, with an eye looking at the viewing window. The device is depicted with a yellow cap on one end and textured grip on the other, indicating how to position the injector for use.*

FDA Label Image

Image (Zembrace 14)

An instructional illustration showing a hand disposing a single-use injection device into a red biohazard sharps container, which has a biohazard symbol and label on the front, indicating proper disposal of medical sharps waste.*

FDA Label Image

Principal Display Panel (3 mg Syringe Blister Pack Carton)

Box packaging label for Zembrace SymTouch sumatriptan injection, 3 mg strength. The label shows it is a subcutaneous solution delivered via an auto-injector with 0.5 mL sterile solution. Manufactured for Tonix Medicines, Inc. Storage instructions note to store at 20° to 25°C (68° to 77°F) and to protect from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.